In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 23, Issue 2, 2001, Pages 61-64

  Palacin C ^a   Tarrago C ^a   Agut, J ^a   Guglietta, A ^a  

^a Ctro de Investigacion Farmaceut G   (Spain)

Author keywords

Candida spp.; In vitro activity; Sertaconazole; Vaginal isolates

Indexed keywords

CLOTRIMAZOLE; FENTICONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; SERTACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VAGINA CANDIDIASIS;

EID: 0034952604     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2001.23.2.627926     Document Type: Article

References (21)

1. Pathogenesis and epidemiology of vulvovaginal candidiasis
2. Update on treatment of vulvovaginal candidiasis
3. Systemic vs. topical therapy for the treatment of vulvo-vaginal candidiasis
4. Vulvovaginitis due to Candida glabrata. An emerging problem
5. Managing patients with vulvovaginal candidiasis
6. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis (RVVC)
7. Nuevos antiúngicos: Sertaconazol
8. Prevalence of risk factors for fungal vaginitis caused by non-albicans species
9. Patógenos fúngicos emergentes
10. Epidemiological shifts in opportunistic and nosocomial Candida infections. Mycological aspects
11. Epidemiology of mycoses in the HIV-infected patient: Clinical aspects
12. Azole resistance in Candida
13. In vitro activity of cloconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
14. Fluconazole resistance in Candida glabrata
15. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans
16. Antifungal agents in the 1990s. Current status and future developments
17. Sensibilidad al fluconazol y a la anfotericina B en cepas de Candida provenientes de aislamientos clínicos
18. In vitro antifungal activity of serfaconazole
19. In vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus
20. Tolerance and kinetic behavior after single and repeated vaginal administration of sertaconazole cream and tablets in healthy volunteers
21. Caractéristiques pharmacocinetiques d'un nouvel antifongique amidazole: Le nitrate de sertaconazole